Regenxbio Inc (RGNX) operating margin is 13.6%
Regenxbio Inc (RGNX) operating margin is 13.6% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full RGNX research page for quote, filings, and the rest of the model. This satellite exists so “Regenxbio Inc operating margin” can rank with the actual number, then send you to /stock/rgnx.